SPARK Europe Webinar Series - Telik Sory: The rise and fall of a biotech company

In this webinar, Dr. Steven Schow will tell the 21-year story of Telik, Inc., a biotech start-up that at one point, was valued at ~$1.5 billion USD but finally faded into obscurity. Drawing on his experience as Vice President of R&D at Telik, Dr. Schow will share insights into the company's rise, challenges, and the lessons learned from its demise. With more than 45 years of experience in pharmaceutical and biotechnology research and development, he will also offer valuable insights into the biotechnology and drug development landscape. An advisor to SPARK since 2008, Dr. Schow brings additional expertise in mentoring drug development teams and guiding business development in the biotech sector.